Skip to main page content

Comment

. 2015 Mar;12(3):131.

doi: 10.1038/nrcardio.2015.4. Epub 2015 Jan 27.

Dyslipidaemia: Statin therapy in men versus women

PMID: 25622849
DOI: 10.1038/nrcardio.2015.4

Comment

Dyslipidaemia: Statin therapy in men versus women

Gregory B Lim. Nat Rev Cardiol. 2015 Mar.

. 2015 Mar;12(3):131.

doi: 10.1038/nrcardio.2015.4. Epub 2015 Jan 27.

Author

PMID: 25622849
DOI: 10.1038/nrcardio.2015.4

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration; Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech A. Cholesterol Treatment Trialists' (CTT) Collaboration, et al. Lancet. 2015 Apr 11;385(9976):1397-405. doi: 10.1016/S0140-6736(14)61368-4. Epub 2015 Jan 9. Lancet. 2015. PMID: 25579834

Similar articles

Cholesterol Levels Should Play a More Important Role in Identifying Statin Recipients.
Durrington PN, Soran H. Durrington PN, et al. Circulation. 2017 Feb 14;135(7):627-629. doi: 10.1161/CIRCULATIONAHA.116.022146. Circulation. 2017. PMID: 28193795 Review. No abstract available.
[Statin in the primary and secondary prevention of cardiovascular disease].
Tamaru H, Ishihara M. Tamaru H, et al. Nihon Rinsho. 2016 Jun 20;74 Suppl 4 Pt 1:556-61. Nihon Rinsho. 2016. PMID: 27534231 Japanese. No abstract available.
Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
Ferrières J, Bérard E, Crisan O, Bongard V. Ferrières J, et al. Arch Cardiovasc Dis. 2010 May;103(5):302-9. doi: 10.1016/j.acvd.2010.04.003. Epub 2010 Jun 4. Arch Cardiovasc Dis. 2010. PMID: 20619240
Statin effects in CKD: is there a "point of no return"?
Wanner C. Wanner C. Am J Kidney Dis. 2009 May;53(5):723-5. doi: 10.1053/j.ajkd.2009.02.002. Am J Kidney Dis. 2009. PMID: 19393469 No abstract available.
High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Toth PP, Davidson MH. Toth PP, et al. J Fam Pract. 2008 May;57(5 Suppl High-Dose):S29-36. J Fam Pract. 2008. PMID: 18662521 Review. No abstract available.

See all similar articles

References

1. Lancet. 2015 Apr 11;385(9976):1397-405 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information